Haleon HLN
NYSE HLN
$9.85 -0.02 (-0.20%)
At close: Aug 20, 2026 · 10:53 AM UTC

Haleon (HLN) EBT Margin Growth (1y) (2022 - 2023)

Haleon (HLN) EBT Margin Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Haleon 43.76 Bn 42.79 Bn - -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn -1,585.00
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn -177.00
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn -27.00
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn -356.00
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn 436.00
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn -629.00
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 208.00
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn -2,721.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -3,467.00
Dec 31, 2022 3,414.00